Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Avid Bioservices Q4 2024 GAAP EPS $(1.94) vs $(0.04) Estimate, Sales $43.000M Beat $42.142M Estimate

Author: Benzinga Newsdesk | July 02, 2024 04:06pm

Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(1.94) per share which missed the analyst consensus estimate of $(0.04) by 4750 percent. The company reported quarterly sales of $43.000 million which beat the analyst consensus estimate of $42.142 million by 2.04 percent. This is a 8.04 percent increase over sales of $39.799 million the same period last year.

Posted In: CDMO